These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38074683)

  • 41. Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy.
    Liu Z; Yu Z; Chen D; Verma V; Yuan C; Wang M; Wang F; Fan Q; Wang X; Li Y; Ma Y; Wu M; Yu J
    Cancer Commun (Lond); 2022 Oct; 42(10):971-986. PubMed ID: 35962977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Assessment of the risk factors relating to lymph node metastasis in rectal cancer after neoadjuvant chemoradiotherapy and the clinical significance].
    Zhao Q; Shi X; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1040-1043. PubMed ID: 27680075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated CD8+ T cell infiltration to control mucosal tumor growth.
    Qiu J; Peng S; Yang A; Ma Y; Han L; Cheng MA; Farmer E; Hung CF; Wu TC
    Oncoimmunology; 2018; 7(8):e1463946. PubMed ID: 30221059
    [No Abstract]   [Full Text] [Related]  

  • 45. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
    Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
    Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
    Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison between preoperative chemoradiotherapy and lateral pelvic lymph node dissection in clinical T3 low rectal cancer without enlarged lateral lymph nodes.
    Tsukada Y; Rullier E; Shiraishi T; Capdepont M; Sasaki T; Celerier B; Denost Q; Ito M
    Colorectal Dis; 2023 Jun; 25(6):1153-1162. PubMed ID: 36932710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory B cells producing IL-10 are increased in human tumor draining lymph nodes.
    Piersiala K; Hjalmarsson E; da Silva PFN; Lagebro V; Kolev A; Starkhammar M; Elliot A; Marklund L; Munck-Wikland E; Margolin G; Georén SK; Cardell LO
    Int J Cancer; 2023 Aug; 153(4):854-866. PubMed ID: 37144812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.
    Zuckerman NS; Yu H; Simons DL; Bhattacharya N; Carcamo-Cavazos V; Yan N; Dirbas FM; Johnson DL; Schwartz EJ; Lee PP
    Int J Cancer; 2013 Jun; 132(11):2537-47. PubMed ID: 23136075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
    Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
    Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes.
    Jeanbart L; Ballester M; de Titta A; Corthésy P; Romero P; Hubbell JA; Swartz MA
    Cancer Immunol Res; 2014 May; 2(5):436-47. PubMed ID: 24795356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The tumor-draining lymph node as an immune-privileged site.
    Munn DH; Mellor AL
    Immunol Rev; 2006 Oct; 213():146-58. PubMed ID: 16972902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo lymph node mapping and pattern of metastasis spread in locally advanced mid/low rectal cancer after neoadjuvant chemoradiotherapy.
    Farinella E; Viganò L; Fava MC; Mineccia M; Bertolino F; Capussotti L
    Int J Colorectal Dis; 2013 Nov; 28(11):1523-9. PubMed ID: 23877264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
    Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
    Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
    Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
    Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy.
    Mei SW; Liu Z; Wang Z; Pei W; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Wang XS; Liu Q
    World J Clin Cases; 2020 Dec; 8(24):6229-6242. PubMed ID: 33392304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathological complete response to neoadjuvant chemoimmunotherapy correlates with peripheral blood immune cell subsets and metastatic status of mediastinal lymph nodes (N2 lymph nodes) in non-small cell lung cancer.
    Ma T; Wen T; Cheng X; Wang Y; Wei P; Yang B; Yi L; Wang X; Yan Z; Wang J; Liu Z
    Lung Cancer; 2022 Oct; 172():43-52. PubMed ID: 35988509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.
    Tang H; Jiang D; Zhang S; Zeng Z; Tan L; Hou Y; Wang Q; ; Wang H; Zhu J; Shen Y; Yin J; Ge D
    J Thorac Cardiovasc Surg; 2021 Dec; 162(6):1632-1641. PubMed ID: 33268125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
    Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.